nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—SULT1E1—coronary artery disease	0.459	1	CbGaD
Cyclizine—Flunarizine—Ezetimibe—coronary artery disease	0.177	1	CrCrCtD
Cyclizine—CYP2C9—Fenofibrate—coronary artery disease	0.0312	0.154	CbGbCtD
Cyclizine—CYP2C9—Gemfibrozil—coronary artery disease	0.0249	0.123	CbGbCtD
Cyclizine—CYP2C9—Clopidogrel—coronary artery disease	0.0216	0.107	CbGbCtD
Cyclizine—CYP2C9—Pitavastatin—coronary artery disease	0.0189	0.0931	CbGbCtD
Cyclizine—CYP2C9—Valsartan—coronary artery disease	0.0184	0.0906	CbGbCtD
Cyclizine—CYP2C9—Rosuvastatin—coronary artery disease	0.0139	0.0686	CbGbCtD
Cyclizine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0136	0.0669	CbGbCtD
Cyclizine—CYP2C9—Simvastatin—coronary artery disease	0.013	0.0638	CbGbCtD
Cyclizine—CYP2C9—Pravastatin—coronary artery disease	0.0127	0.0625	CbGbCtD
Cyclizine—CYP2C9—Lovastatin—coronary artery disease	0.0127	0.0625	CbGbCtD
Cyclizine—CYP2C9—Atorvastatin—coronary artery disease	0.0116	0.0569	CbGbCtD
Cyclizine—CYP2C9—Losartan—coronary artery disease	0.0106	0.052	CbGbCtD
Cyclizine—CYP2C9—cardial valve—coronary artery disease	0.00597	0.459	CbGeAlD
Cyclizine—SULT1E1—myocardium—coronary artery disease	0.00261	0.2	CbGeAlD
Cyclizine—SULT1E1—heart—coronary artery disease	0.00182	0.14	CbGeAlD
Cyclizine—SULT1E1—cardiovascular system—coronary artery disease	0.00172	0.132	CbGeAlD
Cyclizine—Phenprocoumon—VKORC1—coronary artery disease	0.000482	0.242	CrCbGaD
Cyclizine—CYP2C9—heart—coronary artery disease	0.00033	0.0254	CbGeAlD
Cyclizine—CYP2C9—cardiovascular system—coronary artery disease	0.000311	0.0239	CbGeAlD
Cyclizine—CYP2C9—blood—coronary artery disease	0.000246	0.0189	CbGeAlD
Cyclizine—Bepridil—ATP1A1—coronary artery disease	0.000201	0.101	CrCbGaD
Cyclizine—Mianserin—HRH2—coronary artery disease	0.000194	0.0973	CrCbGaD
Cyclizine—Loxapine—HRH2—coronary artery disease	0.000154	0.0773	CrCbGaD
Cyclizine—Fentanyl—OPRD1—coronary artery disease	0.000119	0.0597	CrCbGaD
Cyclizine—Agranulocytosis—Lisinopril—coronary artery disease	0.000119	0.00138	CcSEcCtD
Cyclizine—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000118	0.00137	CcSEcCtD
Cyclizine—Anaphylactic shock—Telmisartan—coronary artery disease	0.000118	0.00137	CcSEcCtD
Cyclizine—Hypertension—Perindopril—coronary artery disease	0.000117	0.00136	CcSEcCtD
Cyclizine—Nervous system disorder—Trandolapril—coronary artery disease	0.000117	0.00136	CcSEcCtD
Cyclizine—Agitation—Losartan—coronary artery disease	0.000117	0.00136	CcSEcCtD
Cyclizine—Hypotension—Niacin—coronary artery disease	0.000117	0.00136	CcSEcCtD
Cyclizine—Tachycardia—Trandolapril—coronary artery disease	0.000117	0.00136	CcSEcCtD
Cyclizine—Constipation—Simvastatin—coronary artery disease	0.000117	0.00135	CcSEcCtD
Cyclizine—Pain—Simvastatin—coronary artery disease	0.000117	0.00135	CcSEcCtD
Cyclizine—Angioedema—Losartan—coronary artery disease	0.000117	0.00135	CcSEcCtD
Cyclizine—Urticaria—Clopidogrel—coronary artery disease	0.000117	0.00135	CcSEcCtD
Cyclizine—Insomnia—Valsartan—coronary artery disease	0.000116	0.00135	CcSEcCtD
Cyclizine—Tachycardia—Enalapril—coronary artery disease	0.000116	0.00135	CcSEcCtD
Cyclizine—Skin disorder—Trandolapril—coronary artery disease	0.000116	0.00135	CcSEcCtD
Cyclizine—Insomnia—Olmesartan—coronary artery disease	0.000116	0.00135	CcSEcCtD
Cyclizine—Urticaria—Lovastatin—coronary artery disease	0.000116	0.00135	CcSEcCtD
Cyclizine—Paraesthesia—Valsartan—coronary artery disease	0.000116	0.00134	CcSEcCtD
Cyclizine—Nervous system disorder—Telmisartan—coronary artery disease	0.000115	0.00134	CcSEcCtD
Cyclizine—Eye disorder—Timolol—coronary artery disease	0.000115	0.00133	CcSEcCtD
Cyclizine—Tachycardia—Telmisartan—coronary artery disease	0.000115	0.00133	CcSEcCtD
Cyclizine—Somnolence—Valsartan—coronary artery disease	0.000114	0.00133	CcSEcCtD
Cyclizine—Anaphylactic shock—Captopril—coronary artery disease	0.000114	0.00133	CcSEcCtD
Cyclizine—Skin disorder—Telmisartan—coronary artery disease	0.000114	0.00133	CcSEcCtD
Cyclizine—Hepatitis—Lisinopril—coronary artery disease	0.000114	0.00132	CcSEcCtD
Cyclizine—Dizziness—Rosuvastatin—coronary artery disease	0.000114	0.00132	CcSEcCtD
Cyclizine—Urticaria—Ezetimibe—coronary artery disease	0.000114	0.00132	CcSEcCtD
Cyclizine—Insomnia—Niacin—coronary artery disease	0.000113	0.00132	CcSEcCtD
Cyclizine—Paraesthesia—Niacin—coronary artery disease	0.000112	0.00131	CcSEcCtD
Cyclizine—Hypotension—Trandolapril—coronary artery disease	0.000112	0.0013	CcSEcCtD
Cyclizine—Tachycardia—Captopril—coronary artery disease	0.000112	0.0013	CcSEcCtD
Cyclizine—Insomnia—Pravastatin—coronary artery disease	0.000111	0.0013	CcSEcCtD
Cyclizine—Hypotension—Enalapril—coronary artery disease	0.000111	0.00129	CcSEcCtD
Cyclizine—Somnolence—Niacin—coronary artery disease	0.000111	0.00129	CcSEcCtD
Cyclizine—Anaphylactic shock—Perindopril—coronary artery disease	0.000111	0.00129	CcSEcCtD
Cyclizine—Paraesthesia—Pravastatin—coronary artery disease	0.000111	0.00129	CcSEcCtD
Cyclizine—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000111	0.00128	CcSEcCtD
Cyclizine—Mental disorder—Ramipril—coronary artery disease	0.00011	0.00128	CcSEcCtD
Cyclizine—Constipation—Valsartan—coronary artery disease	0.00011	0.00128	CcSEcCtD
Cyclizine—Hypersensitivity—Fenofibrate—coronary artery disease	0.00011	0.00128	CcSEcCtD
Cyclizine—Hypotension—Telmisartan—coronary artery disease	0.00011	0.00128	CcSEcCtD
Cyclizine—Pain—Olmesartan—coronary artery disease	0.00011	0.00127	CcSEcCtD
Cyclizine—Constipation—Olmesartan—coronary artery disease	0.00011	0.00127	CcSEcCtD
Cyclizine—Erythema—Ramipril—coronary artery disease	0.000109	0.00127	CcSEcCtD
Cyclizine—Nervous system disorder—Perindopril—coronary artery disease	0.000109	0.00126	CcSEcCtD
Cyclizine—Tachycardia—Perindopril—coronary artery disease	0.000108	0.00126	CcSEcCtD
Cyclizine—Urticaria—Simvastatin—coronary artery disease	0.000108	0.00126	CcSEcCtD
Cyclizine—Insomnia—Trandolapril—coronary artery disease	0.000108	0.00126	CcSEcCtD
Cyclizine—Hypersensitivity—Clopidogrel—coronary artery disease	0.000108	0.00126	CcSEcCtD
Cyclizine—Anaphylactic shock—Furosemide—coronary artery disease	0.000108	0.00125	CcSEcCtD
Cyclizine—Skin disorder—Perindopril—coronary artery disease	0.000108	0.00125	CcSEcCtD
Cyclizine—Insomnia—Enalapril—coronary artery disease	0.000108	0.00125	CcSEcCtD
Cyclizine—Headache—Rosuvastatin—coronary artery disease	0.000108	0.00125	CcSEcCtD
Cyclizine—Mental disorder—Timolol—coronary artery disease	0.000108	0.00125	CcSEcCtD
Cyclizine—Paraesthesia—Trandolapril—coronary artery disease	0.000107	0.00125	CcSEcCtD
Cyclizine—Hypersensitivity—Lovastatin—coronary artery disease	0.000107	0.00125	CcSEcCtD
Cyclizine—Tension—Ramipril—coronary artery disease	0.000107	0.00125	CcSEcCtD
Cyclizine—Asthenia—Fenofibrate—coronary artery disease	0.000107	0.00124	CcSEcCtD
Cyclizine—Pain—Niacin—coronary artery disease	0.000107	0.00124	CcSEcCtD
Cyclizine—Paraesthesia—Enalapril—coronary artery disease	0.000107	0.00124	CcSEcCtD
Cyclizine—Erythema—Timolol—coronary artery disease	0.000107	0.00124	CcSEcCtD
Cyclizine—Hypotension—Captopril—coronary artery disease	0.000107	0.00124	CcSEcCtD
Cyclizine—Somnolence—Trandolapril—coronary artery disease	0.000106	0.00124	CcSEcCtD
Cyclizine—Insomnia—Telmisartan—coronary artery disease	0.000106	0.00124	CcSEcCtD
Cyclizine—Nervousness—Ramipril—coronary artery disease	0.000106	0.00123	CcSEcCtD
Cyclizine—Somnolence—Enalapril—coronary artery disease	0.000106	0.00123	CcSEcCtD
Cyclizine—Nervous system disorder—Furosemide—coronary artery disease	0.000106	0.00123	CcSEcCtD
Cyclizine—Pruritus—Fenofibrate—coronary artery disease	0.000106	0.00123	CcSEcCtD
Cyclizine—Paraesthesia—Telmisartan—coronary artery disease	0.000106	0.00123	CcSEcCtD
Cyclizine—Constipation—Pravastatin—coronary artery disease	0.000105	0.00122	CcSEcCtD
Cyclizine—Pain—Pravastatin—coronary artery disease	0.000105	0.00122	CcSEcCtD
Cyclizine—Hypersensitivity—Ezetimibe—coronary artery disease	0.000105	0.00122	CcSEcCtD
Cyclizine—Asthenia—Clopidogrel—coronary artery disease	0.000105	0.00122	CcSEcCtD
Cyclizine—Muscle spasms—Ramipril—coronary artery disease	0.000105	0.00122	CcSEcCtD
Cyclizine—Tension—Timolol—coronary artery disease	0.000105	0.00122	CcSEcCtD
Cyclizine—Skin disorder—Furosemide—coronary artery disease	0.000105	0.00122	CcSEcCtD
Cyclizine—Asthenia—Lovastatin—coronary artery disease	0.000105	0.00121	CcSEcCtD
Cyclizine—Somnolence—Telmisartan—coronary artery disease	0.000105	0.00121	CcSEcCtD
Cyclizine—Anaphylactic shock—Losartan—coronary artery disease	0.000104	0.00121	CcSEcCtD
Cyclizine—Nervousness—Timolol—coronary artery disease	0.000104	0.00121	CcSEcCtD
Cyclizine—Pruritus—Clopidogrel—coronary artery disease	0.000104	0.00121	CcSEcCtD
Cyclizine—Hypotension—Perindopril—coronary artery disease	0.000104	0.00121	CcSEcCtD
Cyclizine—Insomnia—Captopril—coronary artery disease	0.000103	0.0012	CcSEcCtD
Cyclizine—Pruritus—Lovastatin—coronary artery disease	0.000103	0.0012	CcSEcCtD
Cyclizine—Paraesthesia—Captopril—coronary artery disease	0.000103	0.00119	CcSEcCtD
Cyclizine—Asthenia—Ezetimibe—coronary artery disease	0.000103	0.00119	CcSEcCtD
Cyclizine—Tremor—Ramipril—coronary artery disease	0.000103	0.00119	CcSEcCtD
Cyclizine—Phenoxybenzamine—SLC22A3—coronary artery disease	0.000102	0.0513	CrCbGaD
Cyclizine—Constipation—Trandolapril—coronary artery disease	0.000102	0.00119	CcSEcCtD
Cyclizine—Urticaria—Valsartan—coronary artery disease	0.000102	0.00119	CcSEcCtD
Cyclizine—Chills—Lisinopril—coronary artery disease	0.000102	0.00119	CcSEcCtD
Cyclizine—Nervous system disorder—Losartan—coronary artery disease	0.000102	0.00119	CcSEcCtD
Cyclizine—Constipation—Enalapril—coronary artery disease	0.000102	0.00118	CcSEcCtD
Cyclizine—Urticaria—Olmesartan—coronary artery disease	0.000102	0.00118	CcSEcCtD
Cyclizine—Somnolence—Captopril—coronary artery disease	0.000102	0.00118	CcSEcCtD
Cyclizine—Tachycardia—Losartan—coronary artery disease	0.000102	0.00118	CcSEcCtD
Cyclizine—Pruritus—Ezetimibe—coronary artery disease	0.000101	0.00118	CcSEcCtD
Cyclizine—Hypotension—Furosemide—coronary artery disease	0.000101	0.00117	CcSEcCtD
Cyclizine—Vision blurred—Timolol—coronary artery disease	0.000101	0.00117	CcSEcCtD
Cyclizine—Constipation—Telmisartan—coronary artery disease	0.000101	0.00117	CcSEcCtD
Cyclizine—Pain—Telmisartan—coronary artery disease	0.000101	0.00117	CcSEcCtD
Cyclizine—Agitation—Ramipril—coronary artery disease	0.000101	0.00117	CcSEcCtD
Cyclizine—Hypersensitivity—Simvastatin—coronary artery disease	0.0001	0.00117	CcSEcCtD
Cyclizine—Insomnia—Perindopril—coronary artery disease	0.0001	0.00117	CcSEcCtD
Cyclizine—Asthenia—Eplerenone—coronary artery disease	0.0001	0.00117	CcSEcCtD
Cyclizine—Angioedema—Ramipril—coronary artery disease	0.0001	0.00116	CcSEcCtD
Cyclizine—Mental disorder—Lisinopril—coronary artery disease	9.99e-05	0.00116	CcSEcCtD
Cyclizine—Paraesthesia—Perindopril—coronary artery disease	9.97e-05	0.00116	CcSEcCtD
Cyclizine—Urticaria—Niacin—coronary artery disease	9.95e-05	0.00116	CcSEcCtD
Cyclizine—Erythema—Lisinopril—coronary artery disease	9.92e-05	0.00115	CcSEcCtD
Cyclizine—Pruritus—Eplerenone—coronary artery disease	9.9e-05	0.00115	CcSEcCtD
Cyclizine—Dizziness—Fenofibrate—coronary artery disease	9.87e-05	0.00115	CcSEcCtD
Cyclizine—Somnolence—Perindopril—coronary artery disease	9.87e-05	0.00115	CcSEcCtD
Cyclizine—Urticaria—Pravastatin—coronary artery disease	9.79e-05	0.00114	CcSEcCtD
Cyclizine—Asthenia—Simvastatin—coronary artery disease	9.78e-05	0.00114	CcSEcCtD
Cyclizine—Constipation—Captopril—coronary artery disease	9.78e-05	0.00114	CcSEcCtD
Cyclizine—Angioedema—Timolol—coronary artery disease	9.77e-05	0.00114	CcSEcCtD
Cyclizine—Tension—Lisinopril—coronary artery disease	9.74e-05	0.00113	CcSEcCtD
Cyclizine—Hypotension—Losartan—coronary artery disease	9.73e-05	0.00113	CcSEcCtD
Cyclizine—Dizziness—Clopidogrel—coronary artery disease	9.7e-05	0.00113	CcSEcCtD
Cyclizine—Paraesthesia—Furosemide—coronary artery disease	9.69e-05	0.00113	CcSEcCtD
Cyclizine—Pruritus—Simvastatin—coronary artery disease	9.65e-05	0.00112	CcSEcCtD
Cyclizine—Dizziness—Lovastatin—coronary artery disease	9.64e-05	0.00112	CcSEcCtD
Cyclizine—Nervousness—Lisinopril—coronary artery disease	9.64e-05	0.00112	CcSEcCtD
Cyclizine—Somnolence—Furosemide—coronary artery disease	9.6e-05	0.00111	CcSEcCtD
Cyclizine—Muscle spasms—Lisinopril—coronary artery disease	9.54e-05	0.00111	CcSEcCtD
Cyclizine—Urticaria—Trandolapril—coronary artery disease	9.51e-05	0.0011	CcSEcCtD
Cyclizine—Constipation—Perindopril—coronary artery disease	9.49e-05	0.0011	CcSEcCtD
Cyclizine—Pain—Perindopril—coronary artery disease	9.49e-05	0.0011	CcSEcCtD
Cyclizine—Hypersensitivity—Valsartan—coronary artery disease	9.49e-05	0.0011	CcSEcCtD
Cyclizine—Convulsion—Ramipril—coronary artery disease	9.48e-05	0.0011	CcSEcCtD
Cyclizine—Urticaria—Enalapril—coronary artery disease	9.47e-05	0.0011	CcSEcCtD
Cyclizine—Dizziness—Ezetimibe—coronary artery disease	9.46e-05	0.0011	CcSEcCtD
Cyclizine—Insomnia—Losartan—coronary artery disease	9.42e-05	0.00109	CcSEcCtD
Cyclizine—Headache—Fenofibrate—coronary artery disease	9.35e-05	0.00109	CcSEcCtD
Cyclizine—Vision blurred—Lisinopril—coronary artery disease	9.35e-05	0.00109	CcSEcCtD
Cyclizine—Paraesthesia—Losartan—coronary artery disease	9.35e-05	0.00109	CcSEcCtD
Cyclizine—Urticaria—Telmisartan—coronary artery disease	9.34e-05	0.00109	CcSEcCtD
Cyclizine—Tremor—Lisinopril—coronary artery disease	9.3e-05	0.00108	CcSEcCtD
Cyclizine—Somnolence—Losartan—coronary artery disease	9.26e-05	0.00108	CcSEcCtD
Cyclizine—Dizziness—Eplerenone—coronary artery disease	9.25e-05	0.00107	CcSEcCtD
Cyclizine—Asthenia—Valsartan—coronary artery disease	9.24e-05	0.00107	CcSEcCtD
Cyclizine—Hypertension—Timolol—coronary artery disease	9.24e-05	0.00107	CcSEcCtD
Cyclizine—Constipation—Furosemide—coronary artery disease	9.23e-05	0.00107	CcSEcCtD
Cyclizine—Pain—Furosemide—coronary artery disease	9.23e-05	0.00107	CcSEcCtD
Cyclizine—Hypersensitivity—Niacin—coronary artery disease	9.22e-05	0.00107	CcSEcCtD
Cyclizine—Asthenia—Olmesartan—coronary artery disease	9.19e-05	0.00107	CcSEcCtD
Cyclizine—Headache—Clopidogrel—coronary artery disease	9.19e-05	0.00107	CcSEcCtD
Cyclizine—Headache—Lovastatin—coronary artery disease	9.13e-05	0.00106	CcSEcCtD
Cyclizine—Pruritus—Valsartan—coronary artery disease	9.11e-05	0.00106	CcSEcCtD
Cyclizine—Hypersensitivity—Pravastatin—coronary artery disease	9.08e-05	0.00105	CcSEcCtD
Cyclizine—Angioedema—Lisinopril—coronary artery disease	9.07e-05	0.00105	CcSEcCtD
Cyclizine—Pruritus—Olmesartan—coronary artery disease	9.07e-05	0.00105	CcSEcCtD
Cyclizine—Dizziness—Simvastatin—coronary artery disease	9.02e-05	0.00105	CcSEcCtD
Cyclizine—Asthenia—Niacin—coronary artery disease	8.98e-05	0.00104	CcSEcCtD
Cyclizine—Headache—Ezetimibe—coronary artery disease	8.96e-05	0.00104	CcSEcCtD
Cyclizine—Anaphylactic shock—Ramipril—coronary artery disease	8.93e-05	0.00104	CcSEcCtD
Cyclizine—Pain—Losartan—coronary artery disease	8.91e-05	0.00103	CcSEcCtD
Cyclizine—Constipation—Losartan—coronary artery disease	8.91e-05	0.00103	CcSEcCtD
Cyclizine—Pruritus—Niacin—coronary artery disease	8.86e-05	0.00103	CcSEcCtD
Cyclizine—Asthenia—Pravastatin—coronary artery disease	8.84e-05	0.00103	CcSEcCtD
Cyclizine—Urticaria—Perindopril—coronary artery disease	8.82e-05	0.00102	CcSEcCtD
Cyclizine—Hypersensitivity—Trandolapril—coronary artery disease	8.82e-05	0.00102	CcSEcCtD
Cyclizine—Hypersensitivity—Enalapril—coronary artery disease	8.78e-05	0.00102	CcSEcCtD
Cyclizine—Headache—Eplerenone—coronary artery disease	8.77e-05	0.00102	CcSEcCtD
Cyclizine—Nervous system disorder—Ramipril—coronary artery disease	8.76e-05	0.00102	CcSEcCtD
Cyclizine—Anaphylactic shock—Timolol—coronary artery disease	8.73e-05	0.00101	CcSEcCtD
Cyclizine—Pruritus—Pravastatin—coronary artery disease	8.72e-05	0.00101	CcSEcCtD
Cyclizine—Tachycardia—Ramipril—coronary artery disease	8.72e-05	0.00101	CcSEcCtD
Cyclizine—Skin disorder—Ramipril—coronary artery disease	8.67e-05	0.00101	CcSEcCtD
Cyclizine—Hypersensitivity—Telmisartan—coronary artery disease	8.66e-05	0.00101	CcSEcCtD
Cyclizine—Asthenia—Trandolapril—coronary artery disease	8.59e-05	0.000998	CcSEcCtD
Cyclizine—Urticaria—Furosemide—coronary artery disease	8.57e-05	0.000996	CcSEcCtD
Cyclizine—Nervous system disorder—Timolol—coronary artery disease	8.56e-05	0.000994	CcSEcCtD
Cyclizine—Asthenia—Enalapril—coronary artery disease	8.55e-05	0.000994	CcSEcCtD
Cyclizine—Headache—Simvastatin—coronary artery disease	8.54e-05	0.000992	CcSEcCtD
Cyclizine—Dizziness—Valsartan—coronary artery disease	8.52e-05	0.000989	CcSEcCtD
Cyclizine—Skin disorder—Timolol—coronary artery disease	8.48e-05	0.000985	CcSEcCtD
Cyclizine—Dizziness—Olmesartan—coronary artery disease	8.47e-05	0.000984	CcSEcCtD
Cyclizine—Pruritus—Trandolapril—coronary artery disease	8.47e-05	0.000984	CcSEcCtD
Cyclizine—Asthenia—Telmisartan—coronary artery disease	8.44e-05	0.00098	CcSEcCtD
Cyclizine—Pruritus—Enalapril—coronary artery disease	8.44e-05	0.00098	CcSEcCtD
Cyclizine—Hypotension—Ramipril—coronary artery disease	8.34e-05	0.000969	CcSEcCtD
Cyclizine—Pruritus—Telmisartan—coronary artery disease	8.32e-05	0.000966	CcSEcCtD
Cyclizine—Dizziness—Niacin—coronary artery disease	8.28e-05	0.000962	CcSEcCtD
Cyclizine—Urticaria—Losartan—coronary artery disease	8.27e-05	0.000961	CcSEcCtD
Cyclizine—Asthenia—Captopril—coronary artery disease	8.21e-05	0.000953	CcSEcCtD
Cyclizine—Hypotension—Timolol—coronary artery disease	8.16e-05	0.000948	CcSEcCtD
Cyclizine—Dizziness—Pravastatin—coronary artery disease	8.15e-05	0.000947	CcSEcCtD
Cyclizine—Anaphylactic shock—Lisinopril—coronary artery disease	8.1e-05	0.000941	CcSEcCtD
Cyclizine—Pruritus—Captopril—coronary artery disease	8.09e-05	0.00094	CcSEcCtD
Cyclizine—Insomnia—Ramipril—coronary artery disease	8.08e-05	0.000938	CcSEcCtD
Cyclizine—Headache—Valsartan—coronary artery disease	8.07e-05	0.000937	CcSEcCtD
Cyclizine—Headache—Olmesartan—coronary artery disease	8.03e-05	0.000933	CcSEcCtD
Cyclizine—Paraesthesia—Ramipril—coronary artery disease	8.02e-05	0.000931	CcSEcCtD
Cyclizine—Asthenia—Perindopril—coronary artery disease	7.97e-05	0.000925	CcSEcCtD
Cyclizine—Hypersensitivity—Furosemide—coronary artery disease	7.95e-05	0.000924	CcSEcCtD
Cyclizine—Somnolence—Ramipril—coronary artery disease	7.94e-05	0.000922	CcSEcCtD
Cyclizine—Dizziness—Trandolapril—coronary artery disease	7.92e-05	0.00092	CcSEcCtD
Cyclizine—Tachycardia—Lisinopril—coronary artery disease	7.9e-05	0.000918	CcSEcCtD
Cyclizine—Insomnia—Timolol—coronary artery disease	7.9e-05	0.000917	CcSEcCtD
Cyclizine—Dizziness—Enalapril—coronary artery disease	7.88e-05	0.000916	CcSEcCtD
Cyclizine—Skin disorder—Lisinopril—coronary artery disease	7.87e-05	0.000914	CcSEcCtD
Cyclizine—Pruritus—Perindopril—coronary artery disease	7.86e-05	0.000912	CcSEcCtD
Cyclizine—Headache—Niacin—coronary artery disease	7.84e-05	0.000911	CcSEcCtD
Cyclizine—Paraesthesia—Timolol—coronary artery disease	7.84e-05	0.000911	CcSEcCtD
Cyclizine—Dizziness—Telmisartan—coronary artery disease	7.78e-05	0.000903	CcSEcCtD
Cyclizine—Somnolence—Timolol—coronary artery disease	7.76e-05	0.000901	CcSEcCtD
Cyclizine—Asthenia—Furosemide—coronary artery disease	7.74e-05	0.0009	CcSEcCtD
Cyclizine—Headache—Pravastatin—coronary artery disease	7.72e-05	0.000897	CcSEcCtD
Cyclizine—Hypersensitivity—Losartan—coronary artery disease	7.67e-05	0.000891	CcSEcCtD
Cyclizine—Pruritus—Furosemide—coronary artery disease	7.64e-05	0.000887	CcSEcCtD
Cyclizine—Constipation—Ramipril—coronary artery disease	7.64e-05	0.000887	CcSEcCtD
Cyclizine—Hypotension—Lisinopril—coronary artery disease	7.57e-05	0.000879	CcSEcCtD
Cyclizine—Dizziness—Captopril—coronary artery disease	7.56e-05	0.000878	CcSEcCtD
Cyclizine—Headache—Trandolapril—coronary artery disease	7.5e-05	0.000871	CcSEcCtD
Cyclizine—Asthenia—Losartan—coronary artery disease	7.47e-05	0.000868	CcSEcCtD
Cyclizine—Headache—Enalapril—coronary artery disease	7.47e-05	0.000868	CcSEcCtD
Cyclizine—Pain—Timolol—coronary artery disease	7.47e-05	0.000867	CcSEcCtD
Cyclizine—Bifonazole—CYP2C19—coronary artery disease	7.41e-05	0.0371	CrCbGaD
Cyclizine—Pruritus—Losartan—coronary artery disease	7.37e-05	0.000856	CcSEcCtD
Cyclizine—Headache—Telmisartan—coronary artery disease	7.37e-05	0.000856	CcSEcCtD
Cyclizine—Dizziness—Perindopril—coronary artery disease	7.34e-05	0.000853	CcSEcCtD
Cyclizine—Insomnia—Lisinopril—coronary artery disease	7.32e-05	0.000851	CcSEcCtD
Cyclizine—Paraesthesia—Lisinopril—coronary artery disease	7.27e-05	0.000845	CcSEcCtD
Cyclizine—Somnolence—Lisinopril—coronary artery disease	7.2e-05	0.000836	CcSEcCtD
Cyclizine—Headache—Captopril—coronary artery disease	7.16e-05	0.000832	CcSEcCtD
Cyclizine—Dizziness—Furosemide—coronary artery disease	7.14e-05	0.000829	CcSEcCtD
Cyclizine—Urticaria—Ramipril—coronary artery disease	7.09e-05	0.000824	CcSEcCtD
Cyclizine—Headache—Perindopril—coronary artery disease	6.96e-05	0.000808	CcSEcCtD
Cyclizine—Urticaria—Timolol—coronary artery disease	6.94e-05	0.000806	CcSEcCtD
Cyclizine—Constipation—Lisinopril—coronary artery disease	6.93e-05	0.000804	CcSEcCtD
Cyclizine—Pain—Lisinopril—coronary artery disease	6.93e-05	0.000804	CcSEcCtD
Cyclizine—Dizziness—Losartan—coronary artery disease	6.89e-05	0.0008	CcSEcCtD
Cyclizine—Headache—Furosemide—coronary artery disease	6.76e-05	0.000785	CcSEcCtD
Cyclizine—Mianserin—HTR7—coronary artery disease	6.6e-05	0.0331	CrCbGaD
Cyclizine—Benzatropine—CYP2C19—coronary artery disease	6.58e-05	0.033	CrCbGaD
Cyclizine—Hypersensitivity—Ramipril—coronary artery disease	6.58e-05	0.000764	CcSEcCtD
Cyclizine—Headache—Losartan—coronary artery disease	6.52e-05	0.000758	CcSEcCtD
Cyclizine—Urticaria—Lisinopril—coronary artery disease	6.43e-05	0.000747	CcSEcCtD
Cyclizine—Hypersensitivity—Timolol—coronary artery disease	6.43e-05	0.000747	CcSEcCtD
Cyclizine—Asthenia—Ramipril—coronary artery disease	6.41e-05	0.000744	CcSEcCtD
Cyclizine—Pruritus—Ramipril—coronary artery disease	6.32e-05	0.000734	CcSEcCtD
Cyclizine—Asthenia—Timolol—coronary artery disease	6.26e-05	0.000728	CcSEcCtD
Cyclizine—Pruritus—Timolol—coronary artery disease	6.18e-05	0.000717	CcSEcCtD
Cyclizine—Hypersensitivity—Lisinopril—coronary artery disease	5.97e-05	0.000693	CcSEcCtD
Cyclizine—Dizziness—Ramipril—coronary artery disease	5.91e-05	0.000686	CcSEcCtD
Cyclizine—Asthenia—Lisinopril—coronary artery disease	5.81e-05	0.000675	CcSEcCtD
Cyclizine—Dizziness—Timolol—coronary artery disease	5.77e-05	0.000671	CcSEcCtD
Cyclizine—Pruritus—Lisinopril—coronary artery disease	5.73e-05	0.000666	CcSEcCtD
Cyclizine—Headache—Ramipril—coronary artery disease	5.59e-05	0.00065	CcSEcCtD
Cyclizine—Headache—Timolol—coronary artery disease	5.47e-05	0.000635	CcSEcCtD
Cyclizine—Dizziness—Lisinopril—coronary artery disease	5.36e-05	0.000622	CcSEcCtD
Cyclizine—Loxapine—HTR7—coronary artery disease	5.25e-05	0.0263	CrCbGaD
Cyclizine—Headache—Lisinopril—coronary artery disease	5.07e-05	0.000589	CcSEcCtD
Cyclizine—Modafinil—CYP2C19—coronary artery disease	4.87e-05	0.0244	CrCbGaD
Cyclizine—Phenoxybenzamine—ADRB2—coronary artery disease	4.69e-05	0.0235	CrCbGaD
Cyclizine—Loxapine—ADRB1—coronary artery disease	4.49e-05	0.0225	CrCbGaD
Cyclizine—Clozapine—HTR7—coronary artery disease	4.41e-05	0.0221	CrCbGaD
Cyclizine—Cyproheptadine—HTR2A—coronary artery disease	4.38e-05	0.0219	CrCbGaD
Cyclizine—Atomoxetine—CYP2C19—coronary artery disease	4.19e-05	0.021	CrCbGaD
Cyclizine—Phenprocoumon—ALB—coronary artery disease	3.72e-05	0.0186	CrCbGaD
Cyclizine—Atomoxetine—HTR2A—coronary artery disease	3.4e-05	0.017	CrCbGaD
Cyclizine—Diphenhydramine—CYP2C19—coronary artery disease	3.38e-05	0.017	CrCbGaD
Cyclizine—Mianserin—HTR2A—coronary artery disease	3.32e-05	0.0166	CrCbGaD
Cyclizine—Clozapine—CYP2C19—coronary artery disease	2.73e-05	0.0137	CrCbGaD
Cyclizine—Loxapine—HTR2A—coronary artery disease	2.64e-05	0.0132	CrCbGaD
Cyclizine—Clozapine—HTR2A—coronary artery disease	2.21e-05	0.0111	CrCbGaD
Cyclizine—HRH1—GPCR downstream signaling—AGTR1—coronary artery disease	9.43e-06	0.000159	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	9.41e-06	0.000159	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PYGB—coronary artery disease	9.38e-06	0.000158	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CKB—coronary artery disease	9.38e-06	0.000158	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PLCB1—coronary artery disease	9.26e-06	0.000156	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TLE4—coronary artery disease	9.23e-06	0.000156	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MEF2A—coronary artery disease	9.23e-06	0.000156	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CXCL10—coronary artery disease	9.21e-06	0.000156	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR7—coronary artery disease	9.06e-06	0.000153	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOA2—coronary artery disease	8.99e-06	0.000152	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRB2—coronary artery disease	8.94e-06	0.000151	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AVPR1A—coronary artery disease	8.88e-06	0.00015	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PRKCE—coronary artery disease	8.83e-06	0.000149	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—DLAT—coronary artery disease	8.82e-06	0.000149	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—COX5B—coronary artery disease	8.82e-06	0.000149	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PFKFB3—coronary artery disease	8.82e-06	0.000149	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTM2—coronary artery disease	8.82e-06	0.000149	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PLIN1—coronary artery disease	8.82e-06	0.000149	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—KNG1—coronary artery disease	8.61e-06	0.000145	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	8.6e-06	0.000145	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—UTS2—coronary artery disease	8.58e-06	0.000145	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AGTR1—coronary artery disease	8.56e-06	0.000145	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NR4A1—coronary artery disease	8.4e-06	0.000142	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	8.38e-06	0.000142	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CXCL10—coronary artery disease	8.36e-06	0.000141	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SULT1E1—coronary artery disease	8.36e-06	0.000141	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—P2RY12—coronary artery disease	8.31e-06	0.00014	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PLCB3—coronary artery disease	8.31e-06	0.00014	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HDAC9—coronary artery disease	8.31e-06	0.00014	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CASR—coronary artery disease	8.23e-06	0.000139	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CX3CR1—coronary artery disease	8.23e-06	0.000139	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRB2—coronary artery disease	8.12e-06	0.000137	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	8.12e-06	0.000137	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GNA12—coronary artery disease	8.07e-06	0.000136	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—BDKRB1—coronary artery disease	8.07e-06	0.000136	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CX3CL1—coronary artery disease	8.07e-06	0.000136	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—P4HB—coronary artery disease	8.07e-06	0.000136	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PRKCE—coronary artery disease	8.02e-06	0.000135	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—EDN1—coronary artery disease	7.99e-06	0.000135	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKR1B1—coronary artery disease	7.97e-06	0.000135	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HK2—coronary artery disease	7.97e-06	0.000135	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CCL5—coronary artery disease	7.93e-06	0.000134	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PPP3R1—coronary artery disease	7.92e-06	0.000134	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADM—coronary artery disease	7.85e-06	0.000132	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—AKT1—coronary artery disease	7.84e-06	0.000132	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CSF2—coronary artery disease	7.81e-06	0.000132	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDE4B—coronary artery disease	7.65e-06	0.000129	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CYBB—coronary artery disease	7.65e-06	0.000129	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC27A1—coronary artery disease	7.64e-06	0.000129	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CXCL8—coronary artery disease	7.64e-06	0.000129	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MMP3—coronary artery disease	7.63e-06	0.000129	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	7.61e-06	0.000129	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CPT1B—coronary artery disease	7.5e-06	0.000127	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LCAT—coronary artery disease	7.5e-06	0.000127	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOA4—coronary artery disease	7.36e-06	0.000124	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EDN1—coronary artery disease	7.26e-06	0.000123	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	7.23e-06	0.000122	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCL5—coronary artery disease	7.2e-06	0.000122	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PRKCD—coronary artery disease	7.14e-06	0.000121	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PDHA1—coronary artery disease	7.11e-06	0.00012	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GCLM—coronary artery disease	7.11e-06	0.00012	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CSF2—coronary artery disease	7.09e-06	0.00012	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCR3—coronary artery disease	6.99e-06	0.000118	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR2A—coronary artery disease	6.99e-06	0.000118	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—C3—coronary artery disease	6.98e-06	0.000118	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CRK—coronary artery disease	6.9e-06	0.000117	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	6.89e-06	0.000116	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP11B2—coronary artery disease	6.88e-06	0.000116	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TXNRD1—coronary artery disease	6.88e-06	0.000116	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ATP2A2—coronary artery disease	6.82e-06	0.000115	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SH2B3—coronary artery disease	6.82e-06	0.000115	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VWF—coronary artery disease	6.82e-06	0.000115	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC22A3—coronary artery disease	6.78e-06	0.000114	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOC3—coronary artery disease	6.77e-06	0.000114	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LDLR—coronary artery disease	6.73e-06	0.000114	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HADH—coronary artery disease	6.68e-06	0.000113	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ARNTL—coronary artery disease	6.68e-06	0.000113	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AGT—coronary artery disease	6.63e-06	0.000112	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PPP2CA—coronary artery disease	6.61e-06	0.000112	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	6.58e-06	0.000111	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL2—coronary artery disease	6.58e-06	0.000111	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCL3—coronary artery disease	6.58e-06	0.000111	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SDC1—coronary artery disease	6.5e-06	0.00011	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—F2R—coronary artery disease	6.5e-06	0.00011	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PRKCD—coronary artery disease	6.49e-06	0.00011	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	6.42e-06	0.000108	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGB—coronary artery disease	6.36e-06	0.000107	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR2A—coronary artery disease	6.35e-06	0.000107	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—C3—coronary artery disease	6.34e-06	0.000107	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOA2—coronary artery disease	6.33e-06	0.000107	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GPX2—coronary artery disease	6.33e-06	0.000107	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	6.33e-06	0.000107	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EDNRB—coronary artery disease	6.3e-06	0.000106	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HK1—coronary artery disease	6.26e-06	0.000106	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GPX4—coronary artery disease	6.26e-06	0.000106	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCG5—coronary artery disease	6.26e-06	0.000106	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SULT1A1—coronary artery disease	6.26e-06	0.000106	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	6.25e-06	0.000106	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—THBS1—coronary artery disease	6.2e-06	0.000105	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HADHA—coronary artery disease	6.18e-06	0.000104	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PSMB5—coronary artery disease	6.14e-06	0.000104	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PSMA6—coronary artery disease	6.14e-06	0.000104	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—F2—coronary artery disease	6.13e-06	0.000103	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTA1—coronary artery disease	6.11e-06	0.000103	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LPA—coronary artery disease	6.04e-06	0.000102	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AGT—coronary artery disease	6.02e-06	0.000102	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EDNRA—coronary artery disease	5.95e-06	0.0001	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRB1—coronary artery disease	5.92e-06	0.0001	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CYBA—coronary artery disease	5.92e-06	0.0001	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DUSP6—coronary artery disease	5.89e-06	9.95e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PLCB3—coronary artery disease	5.85e-06	9.88e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PLAT—coronary artery disease	5.8e-06	9.79e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOA5—coronary artery disease	5.79e-06	9.78e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—P4HB—coronary artery disease	5.68e-06	9.59e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	5.63e-06	9.5e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—BDKRB2—coronary artery disease	5.59e-06	9.44e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL12—coronary artery disease	5.59e-06	9.44e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—POMC—coronary artery disease	5.58e-06	9.43e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	5.58e-06	9.42e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—F2—coronary artery disease	5.57e-06	9.4e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6ST—coronary artery disease	5.54e-06	9.36e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	5.51e-06	9.31e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JUNB—coronary artery disease	5.49e-06	9.27e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PLCB1—coronary artery disease	5.47e-06	9.23e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	5.45e-06	9.2e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR7—coronary artery disease	5.35e-06	9.04e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—VCAN—coronary artery disease	5.26e-06	8.88e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALDOA—coronary artery disease	5.22e-06	8.81e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ITGAV—coronary artery disease	5.1e-06	8.61e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KNG1—coronary artery disease	5.09e-06	8.59e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—POMC—coronary artery disease	5.07e-06	8.56e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CREB1—coronary artery disease	5.07e-06	8.56e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—DCN—coronary artery disease	5.06e-06	8.55e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AGTR1—coronary artery disease	5.06e-06	8.54e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCL2—coronary artery disease	4.96e-06	8.38e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6R—coronary artery disease	4.95e-06	8.35e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL10—coronary artery disease	4.94e-06	8.34e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PLG—coronary artery disease	4.93e-06	8.32e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALDH2—coronary artery disease	4.93e-06	8.32e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.8e-06	8.11e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP2C19—coronary artery disease	4.8e-06	8.11e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	4.8e-06	8.11e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LIPC—coronary artery disease	4.8e-06	8.11e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HBA1—coronary artery disease	4.8e-06	8.11e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRB2—coronary artery disease	4.8e-06	8.1e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOC3—coronary artery disease	4.77e-06	8.06e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LDLR—coronary artery disease	4.74e-06	8.01e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.74e-06	8e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCE—coronary artery disease	4.74e-06	8e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—JAK2—coronary artery disease	4.73e-06	7.99e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SOCS1—coronary artery disease	4.72e-06	7.98e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—S100B—coronary artery disease	4.71e-06	7.96e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTT1—coronary artery disease	4.69e-06	7.91e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC9A1—coronary artery disease	4.69e-06	7.91e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SOCS3—coronary artery disease	4.67e-06	7.88e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GCLC—coronary artery disease	4.63e-06	7.82e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CETP—coronary artery disease	4.63e-06	7.82e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TGFBR2—coronary artery disease	4.61e-06	7.79e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KITLG—coronary artery disease	4.61e-06	7.79e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SDC1—coronary artery disease	4.58e-06	7.73e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STAT5A—coronary artery disease	4.51e-06	7.61e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MMP3—coronary artery disease	4.51e-06	7.61e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOB—coronary artery disease	4.36e-06	7.35e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PSMB5—coronary artery disease	4.33e-06	7.31e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PSMA6—coronary artery disease	4.33e-06	7.31e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CXCL8—coronary artery disease	4.32e-06	7.29e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.32e-06	7.29e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—JAK2—coronary artery disease	4.3e-06	7.26e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EDN1—coronary artery disease	4.29e-06	7.24e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCL5—coronary artery disease	4.25e-06	7.18e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CTGF—coronary artery disease	4.23e-06	7.14e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CSF2—coronary artery disease	4.19e-06	7.07e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGF1—coronary artery disease	4.19e-06	7.07e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMGCR—coronary artery disease	4.19e-06	7.07e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GOT2—coronary artery disease	4.19e-06	7.07e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LPL—coronary artery disease	4.16e-06	7.02e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MEF2C—coronary artery disease	4.12e-06	6.96e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	4.12e-06	6.96e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ITGB3—coronary artery disease	4.02e-06	6.78e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	3.92e-06	6.62e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	3.9e-06	6.59e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.85e-06	6.5e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCD—coronary artery disease	3.83e-06	6.47e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.78e-06	6.38e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR2A—coronary artery disease	3.75e-06	6.33e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—C3—coronary artery disease	3.74e-06	6.32e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.73e-06	6.3e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GGT1—coronary artery disease	3.62e-06	6.11e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GOT1—coronary artery disease	3.62e-06	6.11e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HIF1A—coronary artery disease	3.57e-06	6.03e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AGT—coronary artery disease	3.56e-06	6.01e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOE—coronary artery disease	3.49e-06	5.89e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LEP—coronary artery disease	3.49e-06	5.89e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOA1—coronary artery disease	3.45e-06	5.82e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KDR—coronary artery disease	3.42e-06	5.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	3.39e-06	5.73e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ESR1—coronary artery disease	3.33e-06	5.62e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—F2—coronary artery disease	3.29e-06	5.55e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FN1—coronary artery disease	3.29e-06	5.55e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	3.27e-06	5.53e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	3.25e-06	5.49e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTP1—coronary artery disease	3.25e-06	5.48e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	3.22e-06	5.43e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMOX1—coronary artery disease	3.2e-06	5.41e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CAT—coronary artery disease	3.16e-06	5.34e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KIT—coronary artery disease	3.15e-06	5.31e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOB—coronary artery disease	3.07e-06	5.18e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	3.02e-06	5.1e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—POMC—coronary artery disease	2.99e-06	5.06e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CREB1—coronary artery disease	2.99e-06	5.06e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.98e-06	5.04e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCL2—coronary artery disease	2.93e-06	4.95e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LPL—coronary artery disease	2.93e-06	4.95e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6R—coronary artery disease	2.92e-06	4.93e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IGF1—coronary artery disease	2.88e-06	4.86e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	2.87e-06	4.84e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GPX1—coronary artery disease	2.86e-06	4.83e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CD36—coronary artery disease	2.78e-06	4.7e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.75e-06	4.64e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.74e-06	4.63e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	2.74e-06	4.62e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGF2—coronary artery disease	2.65e-06	4.47e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.64e-06	4.45e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOS3—coronary artery disease	2.61e-06	4.41e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JAK2—coronary artery disease	2.54e-06	4.29e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AGT—coronary artery disease	2.51e-06	4.23e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	2.49e-06	4.2e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOE—coronary artery disease	2.46e-06	4.15e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOA1—coronary artery disease	2.43e-06	4.1e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.32e-06	3.92e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	2.32e-06	3.91e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	2.24e-06	3.78e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CASP3—coronary artery disease	2.22e-06	3.74e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6—coronary artery disease	2.2e-06	3.72e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCND1—coronary artery disease	2.16e-06	3.64e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARG—coronary artery disease	2.14e-06	3.61e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—POMC—coronary artery disease	2.11e-06	3.56e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MMP9—coronary artery disease	2.1e-06	3.54e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	2.03e-06	3.43e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALB—coronary artery disease	1.92e-06	3.25e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.88e-06	3.18e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NOS3—coronary artery disease	1.84e-06	3.11e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.73e-06	2.92e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.69e-06	2.86e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.68e-06	2.84e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.47e-06	2.48e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6—coronary artery disease	1.3e-06	2.2e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT1—coronary artery disease	1.2e-06	2.03e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.04e-06	1.75e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKT1—coronary artery disease	8.46e-07	1.43e-05	CbGpPWpGaD
